title: [Special training therapy to reduce inflammation in Anti-Jo-1 syndrome].
abstract: A 46-year-old patient was frequently seen with a medically treated Anti-Jo-1 syndrome. The patient had already been treated with azathioprine and oral corticosteroids on account of decreasing lung function, dyspnoea, fatigue, and beginning signs of myositis. Although high doses of steroids and azathioprine were administered, the muscleskeletal syndromes increased steadily. The patient used to be an active long-distance runner (20 km), but now was unable to perform that kind of physical exercise. It was decided to start a treatment with the GalileoTM training device for active muscle training of the lower extremities. Before and after three months of training the following assessment was performed: measurement of health-related quality of life (St. Georges respiratory questionnaire, SGRQ), ultrasound measurement of the cross-sectional area of the quadriceps muscle, 6 minute walk test (6 MWT), lung function testing, and assessment of serum markers of inflammation (TNF-alpha, interleukin-8, CRP, CK, myoglobin). After only two months, training with the GalileoTM five times a week has improved the patient's conditions dramatically. The training will be continued.
authors.affiliation: Klinik für Innere Medizin, Schwerpunkt Pneumologie, Philipps-Universität Marburg, Baldingerstrasse 1, Marburg.
authors.forename: T
authors.initials: T
authors.lastname: Greulich
authors.forename: S
authors.initials: S
authors.lastname: Müller
authors.forename: J
authors.initials: J
authors.lastname: Fechtel
authors.forename: C
authors.initials: C
authors.lastname: Nell
authors.forename: A
authors.initials: A
authors.lastname: Holland
authors.forename: J P
authors.initials: JP
authors.lastname: Bach
authors.forename: B
authors.initials: B
authors.lastname: Tackenberg
authors.forename: H
authors.initials: H
authors.lastname: Schubert
authors.forename: K
authors.initials: K
authors.lastname: Kenn
authors.forename: C
authors.initials: C
authors.lastname: Vogelmeier
authors.forename: A R
authors.initials: AR
authors.lastname: Koczulla
mesh_terms: D001327:Autoimmune Diseases / Q000175:diagnosis / Q000276:immunology / Q000534:rehabilitation; D001999:Bronchoscopy; D003131:Combined Modality Therapy; D004867:Equipment Design; D005500:Follow-Up Studies; D005541:Forced Expiratory Volume / Q000502:physiology; D006643:Histidine-tRNA Ligase / Q000276:immunology*; D006801:Humans; D054990:Idiopathic Pulmonary Fibrosis / Q000175:diagnosis / Q000276:immunology / Q000534:rehabilitation*; D018836:Inflammation Mediators / Q000097:blood; D008297:Male; D008875:Middle Aged; D053580:Muscle Strength / Q000502:physiology; D026741:Physical Therapy Modalities / Q000295:instrumentation*; D017285:Polymyositis / Q000175:diagnosis / Q000276:immunology / Q000534:rehabilitation*; D011653:Pulmonary Diffusing Capacity / Q000502:physiology; D014057:Tomography, X-Ray Computed; D014732:Vibration / Q000627:therapeutic use*
chemical_list: D018836:Inflammation Mediators; D006643:Histidine-tRNA Ligase